In a new study, researchers at the University of Copenhagen show that the development of a certain type of immature stem cells – also known as progenitor cells– depends on the quantity of a special protein and interaction with other cells in the body. Many diseases are caused by the loss of certain types of cells, such as the insulin-producing beta cells in diabetes – or dysfunction of cells, as in cancer.
Stem cell researchers have struggled for years to excel at restoring the normal healthy cell types. However, the question is how stem cells can be induced to behave the same way in a petri dish as they do in the body.
Closer To Understanding Cellular Development
The researchers aimed to find out how the insulin-producing beta cells are formed naturally in the pancreas so that this process can be replicated in the laboratory.“We examined how much progenitor cells move around as the pancreas develops in the embryo, and if their journey to distinct areas (so-called niches) within the organ can explain what they eventually will become,” says Henrik Semb, professor and executive director, Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, University of Copenhagen. “We discovered that before the progenitors have decided their fate, they move around a lot.”
He says they could also show that their movement to specific niches, where they acquire their final fate, is determined by how much of the protein P120ctn they produce.By understanding this mechanism, Semb says we can improve our methods for making the correct cell type from stem cells in a petri dish for future cell-replacement therapy of diseases, such as Type 1 diabetes, and get new insight into how to prevent spreading of cancer.
Cell Fate Is Dictated By How “Sticky” The Cell Is
Restoring the function of dysfunctional organs requires understanding of how organ shape emerges and its influence on cell fate. Previous research has generated conflicting results. Some results suggest that the future fate of progenitor cells is predetermined, meaning their fate is decided by inheritance before they end up in their final niche, while other results suggest the opposite, namely that their destiny is determined at their final destination in the environment.
“We, therefore, decided to take a closer look at this problem by examining in greater detail how progenitor cells move around and whether their movements correlate with their final fate,” explains the first author of the study Pia Nyeng, assistant professor, DanStem, University of Copenhagen. “By recording three-dimensional movies of fluorescently labeled individual progenitor cells within the early pancreas, we realized that the progenitor cells, prior to their fate decision, continue to change their positions to shape the architecture of the pancreas.”
This observation strongly indicates that the fates of cells do not appear to be predetermined, but rather determined by the particular niche at their final destination.To examine how the final positioning of cells in the organ is controlled, the researchers found that the signaling protein, P120ctn, plays an important role.
“This protein affects adhesion (stickiness) between the cells. Cells with high expression of P120ctn are more adhesive compared to cells with low expression of P120ctn,” Nyeng says. “We observed that cells with high expression of P120ctn remain in the central part of the pancreas, while cells with low expression of P120ctn migrate toward the peripheral part of the pancreas.”
To test their theory, they reduced adhesion in a few progenitors within the central part of the pancreas by inactivating the gene encoding P120ctn.By using movies to analyze the behavior of these cells, the researchers say that they migrated to the peripheral part of the pancreas and developed into enzyme-producing acinar cells.
Might Slow Down Metastasis
Spreading of cancer is strongly connected to a decrease in the adhesive properties of cancer cells. Decreased adhesion enables the cancer cells in an organ to leave the niche they came from and invade the surrounding tissues, including the blood vessels, to metastasize to other organs.Therefore, cancer research has focused on trying to prevent the decrease in adhesion or to reinstate high adhesion in cancer cells without worrying so much about whether this could lead to higher adhesion than in the healthy cells.
“Our experiments show that what drives segregation of cells is their intrinsic differences in adhesion,” Nyeng says. “This suggests that it is not the cell’s adhesive characteristics per se but rather its relative adhesion to the neighboring cells that dictates whether they will segregate (invade neighboring tissue in cancer).” Therefore, the researchers believe to counteract metastasis, cancer therapy should try to reinstate normal levels of adhesion.